𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hyaluronic acid complexed to biodegradable poly L-arginine for targeted delivery of siRNAs

✍ Scribed by Eun-Joong Kim; Gayong Shim; Kwangmyeung Kim; Ick Chan Kwon; Yu-Kyoung Oh; Chang-Koo Shim

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
675 KB
Volume
11
Category
Article
ISSN
1099-498X

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background

Small interfering RNA (siRNA) has been recognized as a new therapeutic drug to treat various diseases by inhibition of oncogene or viral gene expression. Because hyaluronic acid (HA) has been described as a biocompatible biomaterial, we tested the nanoparticles formed by electrostatic complexation of negatively‐charged HA and cationic poly L‐arginine (PLR) for siRNA delivery systems.

Methods

Different electrostatic complexes of HA and PLR (HPs) were formulated: HP101 with 50% (w/w) HA and HP110 with 9% (w/w) HA.

Results

Gel retardation assays showed that HP101 and HP110 could form complexes with siRNAs. The diameters of these complexes were less than 200 nm. Cellular delivery efficiency of siRNAs by HPs depended on cell surface CD44 density. The HP‐mediated delivery of siRNAs was highest in WM266.4 cells followed by B16F10 cells and COS‐7 cells, in parallel with CD44 surface densities of these cell lines. TC~50~ values (i.e. the HP concentrations at which 50% of cells were viable after treatment) were used as indicators of cytotoxicity. HP101 showed TC~50~ values that were 2‐fold and 23‐fold higher than those of HP110 and PLR, respectively. After delivery into cells, siRNA exerted target‐specific RNA interference effects on mRNA and protein levels. Three days after treatment of red fluorescent protein (RFP)‐expressing B16F10 cells with RFP‐specific siRNA complexed to HP101, cellular fluorescence signals were reduced. Intratumoral administration of RFP‐specific siRNA via HP101 delivery significantly reduced the expression of RFP in tumor tissues.

Conclusions

HP101 may function as a biocompatible polymeric carrier of siRNAs and have possible application to localized siRNA delivery in vivo. Copyright © 2009 John Wiley & Sons, Ltd.

📜 SIMILAR VOLUMES

Hyaluronic acid–polyethyleneimine conjug
Hyaluronic acid–polyethyleneimine conjugate for target specific intracellular delivery of siRNA
✍ Ge Jiang; Kitae Park; Jiseok Kim; Ki Su Kim; Eun Ju Oh; Hyungu Kang; Su-Eun Han; 📂 Article 📅 2008 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 286 KB

## Abstract A novel target specific small interfering RNA (siRNA) delivery system was successfully developed using polyethyleneimine (PEI)–hyaluronic acid (HA) conjugate. Anti‐PGL3‐Luc siRNA was used as a model system suppressing the PGL3‐Luc gene expression. The siRNA/PEI‐HA complex with an averag

Poly[lactic-co-(glycolic acid)]-Grafted
Poly[lactic-co-(glycolic acid)]-Grafted Hyaluronic Acid Copolymer Micelle Nanoparticles for Target-Specific Delivery of Doxorubicin
✍ Hyukjin Lee; Cheol-Hee Ahn; Tae Gwan Park 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 485 KB

## Abstract PLGA‐grafted HA copolymers were synthesized and utilized as target specific micelle carriers for DOX. For grafting hydrophobic PLGA chains onto the backbone of hydrophilic HA, HA was solubilized in an anhydrous DMSO by nano‐complexing with dimethoxy‐PEG. The carboxylic groups of HA were